Genmab | Resultado Líquido



Net Income Alterar Data
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Almirall EUR 7.99M 590K 2024-06
Amarin USD -25134000 26.66M 2024-09
Amgen USD 627M 2.2B 2024-12
argenx SE USD 774.16M 682.75M 2024-12
AstraZeneca USD 2.92B 1.42B 2025-03
Bayer EUR -335000000 3.85B 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Demant DKK 1.19B 588.5M 2024-12
Exelixis USD 139.86M 21.89M 2025-01
Fresenius Medical Care EUR 66.9M 146.1M 2024-12
Galapagos EUR -153403000 178.71M 2025-03
Genmab DKK 3.84B 2.58B 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
GN Store Nord DKK 71M 296M 2025-03
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Insmed USD -235548000 15.02M 2024-12
Lonza CHF 329M 85M 2024-06
Merck EUR 667M 142M 2024-12
Novartis USD 2.82B 371M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
UCB EUR 104M 72M 2024-06



Genmab Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.